Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis

[1]  Takuji Tanaka,et al.  Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity , 2011, Cancer Prevention Research.

[2]  M. Fernández-Figueras,et al.  Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation. , 2011, Microvascular research.

[3]  Jidong Zhang,et al.  Tumor-secreted PGE2 Inhibits CCL5 Production in Activated Macrophages through cAMP/PKA Signaling Pathway* , 2010, The Journal of Biological Chemistry.

[4]  K. Kang,et al.  Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. , 2010, Chemico-biological interactions.

[5]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[6]  S. Akira,et al.  mPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis in mice. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  M. Murakami,et al.  Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models. , 2010, Biochimie.

[8]  K. O'Byrne,et al.  The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer. , 2010, Biochimica et biophysica acta.

[9]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[10]  R. DuBois,et al.  The role of COX-2 in intestinal inflammation and colorectal cancer , 2010, Oncogene.

[11]  M. Hamberg,et al.  Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells , 2009, Proceedings of the National Academy of Sciences.

[12]  S. Akira,et al.  Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis , 2009, The Biochemical journal.

[13]  S. Hembruff,et al.  Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting. , 2009, Cancer therapy.

[14]  W. Kassouf,et al.  Peroxisome proliferator-activated receptor γ in bladder cancer: A promising therapeutic target , 2009, Cancer biology & therapy.

[15]  Nathan T. Ihle,et al.  Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy , 2009, Molecular Cancer Therapeutics.

[16]  P. Clark,et al.  Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. , 2008, Cancer research.

[17]  E. Thompson.  PPARgamma physiology and pathology in gastrointestinal epithelial cells. , 2007, Molecules and cells.

[18]  Ralf Morgenstern,et al.  Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target , 2007, Pharmacological Reviews.

[19]  A. Lucci,et al.  Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells. , 2007, The Journal of surgical research.

[20]  Yoshihito Nakatani.  Regulation of Cytosolic Prostaglandin E Synthase , 2007 .

[21]  Henry J. Lin,et al.  Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice. , 2007, Cancer research.

[22]  I. Tomlinson,et al.  Colorectal cancer and genetic alterations in the Wnt pathway , 2006, Oncogene.

[23]  Kei Yamamoto,et al.  Transgenic Expression of Group V, but Not Group X, Secreted Phospholipase A2 in Mice Leads to Neonatal Lethality because of Lung Dysfunction* , 2006, Journal of Biological Chemistry.

[24]  K. Druey,et al.  Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.

[25]  M. Taketo,et al.  Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. , 2005, Cancer research.

[26]  Robert Riddell,et al.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[27]  J. Scher,et al.  15d-PGJ2: the anti-inflammatory prostaglandin? , 2005, Clinical immunology.

[28]  P. Debré,et al.  Intratumoral CC Chemokine Ligand 5 Overexpression Delays Tumor Growth and Increases Tumor Cell Infiltration1 , 2004, The Journal of Immunology.

[29]  Y. Miller,et al.  Pulmonary Prostacyclin Synthase Overexpression Chemoprevents Tobacco Smoke Lung Carcinogenesis in Mice , 2004, Cancer Research.

[30]  Makoto Murakami,et al.  Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1* , 2004, Journal of Biological Chemistry.

[31]  N. Méthot,et al.  Deletion of Microsomal Prostaglandin E2 (PGE2) Synthase-1 Reduces Inducible and Basal PGE2 Production and Alters the Gastric Prostanoid Profile* , 2004, Journal of Biological Chemistry.

[32]  Hiroko Oshima,et al.  Hyperplastic gastric tumors induced by activated macrophages in COX‐2/mPGES‐1 transgenic mice , 2004, The EMBO journal.

[33]  Thomas Ried,et al.  Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability , 2004, Oncogene.

[34]  P. Russo,et al.  Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Are Overexpressed in Squamous Cell Carcinoma of the Penis , 2004, Clinical Cancer Research.

[35]  Makoto Murakami,et al.  Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. , 2004, Progress in lipid research.

[36]  F. Balkwill,et al.  A chemokine receptor antagonist inhibits experimental breast tumor growth. , 2003, Cancer research.

[37]  Makoto Murakami,et al.  Potential Role of Microsomal Prostaglandin E Synthase-1 in Tumorigenesis* , 2003, Journal of Biological Chemistry.

[38]  H. Nakagama,et al.  Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. , 2003, Gastroenterology.

[39]  P. Nambiar,et al.  Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. , 2003, International journal of oncology.

[40]  B. Aggarwal,et al.  Nuclear transcription factor-kappaB as a target for cancer drug development. , 2002, Leukemia.

[41]  L. Crofford,et al.  Microsomal Prostaglandin E Synthase Is Regulated by Proinflammatory Cytokines and Glucocorticoids in Primary Rheumatoid Synovial Cells1 , 2001, The Journal of Immunology.

[42]  D. Riendeau,et al.  Cloning, Expression, and Up-regulation of Inducible Rat Prostaglandin E Synthase during Lipopolysaccharide-induced Pyresis and Adjuvant-induced Arthritis* , 2001, The Journal of Biological Chemistry.

[43]  R Day,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[44]  Makoto Murakami,et al.  Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.

[45]  Lise,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[46]  B. Samuelsson,et al.  Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[48]  Y. Kanegae,et al.  Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. , 1996, Gene.

[49]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.